Gunnar B Ragnarsson
Overview
Explore the profile of Gunnar B Ragnarsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mikaelsdottir E, Thorleifsson G, Stefansdottir L, Halldorsson G, Sigurdsson J, Lund S, et al.
Commun Biol
. 2021 Sep;
4(1):1132.
PMID: 34580418
Platelets play an important role in hemostasis and other aspects of vascular biology. We conducted a meta-analysis of platelet count GWAS using data on 536,974 Europeans and identified 577 independent...
2.
Chapuis A, Egan D, Bar M, Schmitt T, McAfee M, Paulson K, et al.
Nat Med
. 2019 Jun;
25(7):1064-1072.
PMID: 31235963
Relapse after allogeneic hematopoietic cell transplantation (HCT) is the leading cause of death in patients with acute myeloid leukemia (AML) entering HCT with poor-risk features. When HCT does produce prolonged...
3.
Rafnar T, Sigurjonsdottir G, Stacey S, Halldorsson G, Sulem P, Pardo L, et al.
J Natl Cancer Inst
. 2018 May;
110(9):967-974.
PMID: 29767749
Background: Most pathogenic mutations in the BRCA2 gene carry a high risk of hereditary breast and ovarian cancer (HBOC). However, a stop-gain mutation, K3326* (rs11571833), confers risk of lung cancer...
4.
Chapuis A, Ragnarsson G, Nguyen H, Chaney C, Pufnock J, Schmitt T, et al.
Sci Transl Med
. 2013 Mar;
5(174):174ra27.
PMID: 23447018
Relapse remains a leading cause of death after allogeneic hematopoietic cell transplantation (HCT) for patients with high-risk leukemias. The potentially beneficial donor T cell-mediated graft-versus-leukemia (GVL) effect is often mitigated...
5.
Schmitt T, Ragnarsson G, Greenberg P
Hum Gene Ther
. 2009 Aug;
20(11):1240-8.
PMID: 19702439
T cell-based adoptive immunotherapy has been shown to be a promising treatment for various types of cancer. However, adoptive T cell therapy currently requires the custom isolation and characterization of...
6.
Mikaelsdottir E, Benediktsdottir K, Olafsdottir K, Arnadottir T, Ragnarsson G, Olafsson K, et al.
Gynecol Oncol
. 2003 Apr;
89(1):22-30.
PMID: 12694650
Objective: Cervical cancer is a disease caused in part by an infection with an oncogenic subtype of human papillomavirus (HPV). In this study we analysed all cervical cancer samples diagnosed...